EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gastrointestinal Permeation Enhancers Beyond Sodium Caprate and SNAC ‐ What is Coming Next?

Marilena Bohley iD, Jean-Christophe Leroux iD

Advanced Science · 2024-09 · 11 (33)

DOI: 10.1002/advs.202400843 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Science, online erschienen am 17.06.2024. Verfasst von Marilena Bohley und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, 8093, Switzerland. Hauptthemen laut MEDLINE: Caprylates. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 200 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ETH Zurich Postdoctoral Fellowship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oral peptide delivery is trending again. Among the possible reasons are the recent approvals of two oral peptide formulations, which represent a huge stride in the field. For the first time, gastrointestinal (GI) permeation enhancers (PEs) are leveraged to overcome the main limitation of oral peptide delivery—low permeability through the intestinal epithelium. Despite some success, the application of current PEs, such as salcaprozate sodium (SNAC), sodium caprylate (C8), and sodium caprate (C10), is generally resulting in relatively low oral bioavailabilities (BAs)—even for carefully selected therapeutics. With several hundred peptide‐based drugs presently in the pipeline, there is a huge unmet need for more effective PEs. Aiming to provide useful insights for the development of novel PEs, this review summarizes the biological hurdles to oral peptide delivery with special emphasis on the epithelial barrier. It describes the concepts and action modes of PEs and mentions possible new targets. It further states the benchmark that is set by current PEs, while critically assessing and evaluating emerging PEs regarding translatability, safety, and efficacy. Additionally, examples of novel PEs under preclinical and clinical evaluation and future directions are discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CaprylatesHumansAdministration, OralAnimalsPermeabilityDrug Delivery SystemsPeptidesDecanoic Acids

Stichwörter der Autor:innen

SNACbioavailabilityintestinal permeation enhancersoral peptide deliverysodium caprate

Substanzen

Caprylatesoctanoic acidPeptidesdecanoic acidDecanoic Acids

Autor:innen und Institutionen

  • Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, 8093, Switzerland.

ORCID-Profile: Marilena Bohley, Jean-Christophe Leroux

Förderung

  • ETH Zurich Postdoctoral Fellowship

Zitieren

APA

Bohley, M., & Leroux, J. C. (2024). Gastrointestinal Permeation Enhancers Beyond Sodium Caprate and SNAC ‐ What is Coming Next?. Advanced Science, 11(33). https://doi.org/10.1002/advs.202400843

Vancouver

Bohley M, Leroux JC. Gastrointestinal Permeation Enhancers Beyond Sodium Caprate and SNAC ‐ What is Coming Next?. Advanced Science. 2024;11(33). doi:10.1002/advs.202400843

BibTeX
@article{Bohley2024,
  author = {Bohley, Marilena and Leroux, Jean-Christophe},
  title = {Gastrointestinal Permeation Enhancers Beyond Sodium Caprate and SNAC ‐ What is Coming Next?},
  journal = {Advanced Science},
  year = {2024},
  volume = {11},
  number = {33},
  doi = {10.1002/advs.202400843}
}
Kostenlos starten →